Please check your internet connection and try again.
# Isoxsuprine hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator believed to act through beta-adrenergic stimulation, causing smooth muscle relaxation and vasodilation.
## Primary Indications
* Treatment of peripheral vascular diseases such as arteriosclerosis obliterans, Buerger's disease, and Raynaud's disease.
* Management of intermittent claudication.
* Treatment of cerebrovascular insufficiency.
## Adult Dosing
* **Oral:** 10 mg to 20 mg three to four times daily.
* **Maximum Daily Dose:** Not clearly established, but generally not to exceed 40 mg every 12 hours.
## Pediatric Dosing
* Information regarding pediatric dosing is not well-established. Use is generally not recommended in children.
## Dose Adjustments
* **Hepatic Impairment:** No specific dose adjustments are established. Use with caution.
* **Renal Impairment:** No specific dose adjustments are established. Use with caution.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Do not administer intravenously.
## Adverse Effects
* **Cardiovascular:** Hypotension, tachycardia, dizziness, flushing, peripheral edema.
* **Gastrointestinal:** Nausea, vomiting, abdominal distress, heartburn.
* **Neurological:** Weakness, nervousness, drowsiness, headache.
* **Other:** Rash.
## Key Drug Interactions
* **Antihypertensives:** Isoxsuprine may potentiate the effects of antihypertensive medications, leading to additive hypotension.
* **Sympathomimetic agents:** Concurrent use may lead to exaggerated cardiovascular effects.
## Monitoring
* Blood pressure and heart rate.
* Signs and symptoms of peripheral vascular disease (e.g., improvement in claudication, skin temperature/color).
* Signs of adverse effects.
## Clinical Pearls
* Isoxsuprine is generally considered to have limited efficacy in treating peripheral vascular disease, and its use is controversial.
* It is important to counsel patients on potential side effects, especially hypotension and dizziness, and to advise them to rise slowly from a sitting or lying position.
* The optimal duration of therapy has not been clearly defined.
***
*This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines for complete details and to verify specific dosing and safety information before use.*
